BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 28648940)

  • 21. Papular mycosis fungoides: report of two patients, literature review, and conceptual re-appraisal.
    Noe MH; Drake A; Link BK; Liu V
    J Cutan Pathol; 2013 Aug; 40(8):714-9. PubMed ID: 23651057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycosis Fungoides Associated With Lesions in the Spectrum of Primary Cutaneous CD30+ Lymphoproliferative Disorders: The Same Process or 3 Coexisting Lymphomas?
    Cieza-Díaz DE; Prieto-Torres L; Rodríguez-Pinilla SM; Córdoba Mascuñano R; Manso Alonso R; Machan S; Piris Pinilla MÁ; Requena Caballero L
    Am J Dermatopathol; 2019 Nov; 41(11):846-850. PubMed ID: 30946099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective Analysis of Prognostic Factors in 187 Cases of Transformed Mycosis Fungoides.
    Talpur R; Sui D; Gangar P; Dabaja BS; Duvic M
    Clin Lymphoma Myeloma Leuk; 2016 Jan; 16(1):49-56. PubMed ID: 26702474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TOX expression in different subtypes of cutaneous lymphoma.
    Morimura S; Sugaya M; Suga H; Miyagaki T; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    Arch Dermatol Res; 2014 Nov; 306(9):843-9. PubMed ID: 25216799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of CD30 expression in cutaneous neoplasms.
    Kampa F; Mitteldorf C
    J Cutan Pathol; 2021 Apr; 48(4):495-510. PubMed ID: 33047376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycosis fungoides with epidermal mucinosis: a variant of mycosis fungoides with a spongiosis-like pattern.
    Hu SW; Ratech H; Naeem R; Latkowski JA; Kamino H
    J Cutan Pathol; 2015 Oct; 42(10):730-8. PubMed ID: 26009972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile.
    Saed G; Fivenson DP; Naidu Y; Nickoloff BJ
    J Invest Dermatol; 1994 Jul; 103(1):29-33. PubMed ID: 8027577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL.
    Zoi-Toli O; Vermeer MH; De Vries E; Van Beek P; Meijer CJ; Willemze R
    Br J Dermatol; 2000 Aug; 143(2):313-9. PubMed ID: 10951138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of Sézary's syndrome associated with granulomatous lesions, myelodysplastic syndrome and transformation into CD30-positive large-cell pleomorphic lymphoma.
    Carrozza PM; Kempf W; Kazakov DV; Dummer R; Burg G
    Br J Dermatol; 2002 Sep; 147(3):582-6. PubMed ID: 12207606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor microenvironment in mycosis fungoides and Sézary syndrome.
    Rubio Gonzalez B; Zain J; Rosen ST; Querfeld C
    Curr Opin Oncol; 2016 Jan; 28(1):88-96. PubMed ID: 26632770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease.
    Vermeer MH; Geelen FA; Kummer JA; Meijer CJ; Willemze R
    Am J Pathol; 1999 Apr; 154(4):1203-10. PubMed ID: 10233858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disseminated CD8-positive, CD30-positive cutaneous lymphoproliferative eruption with overlapping features of mycosis fungoides and primary cutaneous anaplastic large cell lymphoma following remote solitary lesional presentation.
    Davick JJ; Mutgi KAJ; Wanat KA; Link BK; Liu V
    J Cutan Pathol; 2017 Aug; 44(8):703-712. PubMed ID: 28497585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.
    Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P
    Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical studies using monoclonal antibodies on lymph nodes from patients with mycosis fungoides and Sézary's syndrome.
    Willemze R; Scheffer E; Meijer CJ
    Am J Pathol; 1985 Jul; 120(1):46-54. PubMed ID: 3893151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal activator protein 1 transcription factor expression in CD30-positive cutaneous large-cell lymphomas.
    Mao X; Orchard G; Russell-Jones R; Whittaker S
    Br J Dermatol; 2007 Nov; 157(5):914-21. PubMed ID: 17725669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD147-Cyclophilin a Interactions Promote Proliferation and Survival of Cutaneous T-Cell Lymphoma.
    Sakamoto M; Miyagaki T; Kamijo H; Oka T; Boki H; Takahashi-Shishido N; Suga H; Sugaya M; Sato S
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycosis fungoides and Sézary's syndrome show distinct histomorphological features.
    Imai S; Burg G; Braun-Falco O
    Dermatologica; 1986; 173(3):131-5. PubMed ID: 3770259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The expression of MUM1 in cutaneous T-cell lymphoproliferative disorders.
    Wasco MJ; Fullen D; Su L; Ma L
    Hum Pathol; 2008 Apr; 39(4):557-63. PubMed ID: 18234282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The expression of CXCR3 and CD30 in mycosis fungoides.
    Nikoo A
    Arch Iran Med; 2012 Mar; 15(3):146-50. PubMed ID: 22369302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.